🇺🇸 FDA
Patent

US 10702525

Pyrimidine derivatives as anti-diabetic agents

granted A61KA61K31/505A61K31/5377

Quick answer

US patent 10702525 (Pyrimidine derivatives as anti-diabetic agents) held by UNITED ARAB EMIRATES UNIVERSITY expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNITED ARAB EMIRATES UNIVERSITY
Grant date
Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/505, A61K31/5377, A61P, A61P3/10